Company intelligence / Profile preview

Navidea Biopharmaceuticals, Inc.

Dublin, Ohio, USAnavidea.com ↗
Ownership
Private
Employees
~15
Development stage
Other
01

Overview

Precision immunodiagnostics & therapeutics using Manocept™, lead asset outlicensed; active clinical-stage programs remain

Therapeutic areas
OncologyImmunologyCardiovascularInfectious Diseases
Modalities
Immunodiagnostic agents (radiolabeled small molecules)Immunotherapeutics[1][4][6]
Industry
Biotech
02

Drug pipeline

11 assets

technetium tc 99m tilmanocept

Approved

10 more assets in the full pipeline.

03

Partnerships

Cardinal Health

Beyond the preview

Go deeper on Navidea Biopharmaceuticals, Inc..

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Navidea Biopharmaceuticals, Inc..

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call